Gentherm
Builds thermal and pneumatic comfort systems for vehicles, plus patient-temperature-management products.
Something off on this page? Send us feedback.
Profile
Supplies climate-controlled seating, interior thermal comfort, lumbar and massage systems, valve systems, electronics, and medical patient-temperature-management products. Automotive work produces almost all revenue and is tied to global vehicle programs, seating integrators, OEM demand, and acquisition integration.
Supplies thermal-management and comfort systems mainly to automotive programs. Automotive products include Climate Control Seats, Climate Control Interiors, Lumbar and Massage Comfort Solutions, Climate and Comfort Electronics, Valve Systems, and other vehicle components.
Medical adds patient-temperature-management systems used across care settings. The business operates through a global manufacturing and engineering footprint, with activity tied to automakers and seat-system integrators across North America, Europe, and Asia.
Execution depends on vehicle production schedules, platform awards, large seating customers, OEM demand, acquisition integration, and the pending Modine Performance Technologies transaction. The current portfolio is shaped by acquisitions that expanded from thermoelectric seating into pneumatic comfort, electronics, valves, and patient temperature management.
Company facts
Key statistics
Year to date +7.3% · Average volume (30d) 463.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 29, 2026 | Roth Capital | Reiterate | Buy | $44 | $50 | |
| Jul 24, 2026 | Stifel Nicolaus | Target | $44 | $59 | ||
| Jul 24, 2026 | Freedom Broker | Downgrade | Buy | Hold | ||
| Jul 20, 2026 | Stifel Nicolaus | Target | $38 | $44 | ||
| Apr 24, 2026 | Stifel Nicolaus | Target | $37 | $38 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026Q2 FY26 | $0.56 | $0.75 | +34.2% | $382.9M | $416.2M | +8.7% | −6.40% |
| Apr 23, 2026Q1 FY26 | $0.53 | $0.84 | +58.5% | $362.2M | $393.7M | +8.7% | +2.87% |
| Feb 19, 2026Q4 FY25 | $0.57 | $0.49 | −14.0% | $371.9M | $382.8M | +2.9% | +8.94% |
| Oct 23, 2025Q3 FY25 | $0.66 | $0.73 | +11.5% | $374.7M | $382.9M | +2.2% | +0.38% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $353.9M | $375.1M | $382.9M | $382.8M | $393.7M | $416.2M | |
| Gross profit | $86.5M | $89.8M | $91.2M | $84.3M | $97.2M | $96.4M | |
| Operating income | $17.1M | $24.0M | $23.9M | $13.1M | $11.3M | $10.7M | |
| Net income | −$128.0K | $477.0K | $14.9M | $3.0M | $4.2M | $4.4M | |
| Diluted EPS | −$0.00 | $0.02 | $0.49 | $0.10 | $0.14 | $0.14 | |
| Gross margin | 24.4% | 23.9% | 23.8% | 22.0% | 24.7% | 23.2% | |
| Operating margin | 4.8% | 6.4% | 6.2% | 3.4% | 2.9% | 2.6% |
Fiscal years (4-quarter sums)FY21 $1.05B · FY22 $1.20B · FY23 $1.47B · FY24 $1.46B · FY25 $1.49B
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $213.2M · Total debt $325.1M · Total assets $1.49B · Shareholders' equity $723.1M
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 30.71M · Float 30.03M · 97.8% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.84M | 15.75% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 1.93M | 6.30% | 13F | Aug 13, 2026 |
| Dimensional Fund Advisors LP | 1.57M | 5.10% | 13G | Jul 14, 2026 |
| Harvey Partners, LLC | 1.33M | 4.32% | 13F | Aug 14, 2026 |
| State Street Corp | 1.31M | 4.26% | 13F | Aug 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | Breisacher Nicholas | officer: Chief Accounting Officer | −925 | $43.21 |
| Jul 29, 2026 | Wayne S. III Kauffman | officer: SVP and General Counsel | −4,700 | $43.21 |
Peers
- Lear
Direct seating thermal-comfort challenger with ComfortMax
- Adient
Complete-seat scale with modular heat, ventilation, and massage features
- Magna
Seating Systems scale around OEM seat-platform awards
- BorgWarner
Propulsion thermal systems and electric heaters overlap in EV content
- Solventum
Bair Hugger patient warming platform for perioperative protocols
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Gentherm | $39.55 | +0.04% | $1.21B | 45.6 | 13.4 | 0.8 | +11.0% |
| Lear | $124.02 | −0.10% | $6.21B | 11.6 | 7.9 | 0.3 | +3.0% |
| Adient | $19.06 | +0.11% | $1.49B | 31.8 | 7.2 | 0.1 | +5.0% |
| Magna | $71.41 | +8.43% | $17.93B | 24.4 | 8.9 | 0.4 | +2.0% |
| BorgWarner | $63.84 | −0.37% | $13.15B | 32.0 | 11.8 | 0.9 | +0.3% |
| Solventum | $90.50 | −0.68% | $15.78B | 11.1 | 13.5 | 1.9 | +2.2% |
| Median | 24.4 | 8.9 | 0.4 | +2.2% |